AMGEN INC AMGN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1983-06-17
AMGEN INC institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 46,042,729 | $14.4B |
| CITADEL ADVISORS LLC | 1,543,963 | $543.2M |
| MILLENNIUM MANAGEMENT LLC | 753,329 | $265.1M |
| D. E. Shaw & Co., Inc. | 292,409 | $102.9M |
| AQR CAPITAL MANAGEMENT LLC | 152,222 | $53.6M |
| TWO SIGMA INVESTMENTS, LP | 88,080 | $31.0M |
| Point72 Asset Management, L.P. | 47,400 | $16.7M |
| Bridgewater Associates, LP | 14,774 | $5.2M |
Source: SEC EDGAR filings · CIK 0000318154 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.